C A Jackevicius

Summary

Affiliation: University of Toronto
Country: Canada

Publications

  1. ncbi request reprint Use of the statins in patients after acute myocardial infarction: does evidence change practice?
    C A Jackevicius
    Pharmacy Department, University Health Network Toronto General Hospital, 200 Elizabeth St, Toronto, Ontario, Canada M5G 2C4
    Arch Intern Med 161:183-8. 2001
  2. doi request reprint Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction
    Cynthia A Jackevicius
    University Health Network and Department of Health Policy, Management, and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
    Circulation 117:1028-36. 2008
  3. ncbi request reprint Concordance between discharge prescriptions and insurance claims in post-myocardial infarction patients
    Cynthia A Jackevicius
    University Health Network, Toronto, ON, Canada
    Pharmacoepidemiol Drug Saf 16:207-15. 2007
  4. ncbi request reprint Acute treatment of myocardial infarction in Canada 1999-2002
    Cynthia A Jackevicius
    Pharmacy Department, University Health Network Toronto General Hospital, Toronto, Ontario M5G 2C4
    Can J Cardiol 21:145-52. 2005
  5. ncbi request reprint Routine use of glycoprotein IIb/IIIa inhibitor therapy is associated with an improved in-hospital outcome after percutaneous coronary intervention: Insights from a large, prospective, single-centre registry
    Cynthia A Jackevicius
    University Health Network, Toronto, Ontario
    Can J Cardiol 21:27-32. 2005
  6. ncbi request reprint Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001
    Cynthia A Jackevicius
    Pharmacy Department, University Health Network Toronto General Hospital, Toronto, Ontario, Canada
    Can J Cardiol 19:1359-66. 2003
  7. ncbi request reprint Adherence with statin therapy in elderly patients with and without acute coronary syndromes
    Cynthia A Jackevicius
    Department of Health Policy, Management, and Evaluation, Pharmacy Department and Women s Health Program, University Health Network Toronto General Hospital, 200 Elizabeth St, Toronto, Ontario, Canada M5G 2C4
    JAMA 288:462-7. 2002
  8. pmc The use of lipid-lowering therapy for secondary prevention in patients undergoing percutaneous coronary intervention
    Jessica M Ma
    Pharmacy Department, Toronto East General Hospital, Canada
    Can J Cardiol 22:419-23. 2006
  9. ncbi request reprint Safety of glycoprotein IIb/IIIa inhibitors in urgent or emergency coronary artery bypass graft surgery
    Doret K F Cheng
    General Medicine, Mount Sinai Hospital, Toronto, Ontario
    Can J Cardiol 20:223-8. 2004
  10. doi request reprint Use of ezetimibe in the United States and Canada
    Cynthia A Jackevicius
    University Health Network, Schulich Heart Centre, Toronto
    N Engl J Med 358:1819-28. 2008

Detail Information

Publications17

  1. ncbi request reprint Use of the statins in patients after acute myocardial infarction: does evidence change practice?
    C A Jackevicius
    Pharmacy Department, University Health Network Toronto General Hospital, 200 Elizabeth St, Toronto, Ontario, Canada M5G 2C4
    Arch Intern Med 161:183-8. 2001
    ....
  2. doi request reprint Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction
    Cynthia A Jackevicius
    University Health Network and Department of Health Policy, Management, and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
    Circulation 117:1028-36. 2008
    ..Our objectives were to characterize, to determine factors of, and to measure outcomes associated with primary nonadherence after AMI...
  3. ncbi request reprint Concordance between discharge prescriptions and insurance claims in post-myocardial infarction patients
    Cynthia A Jackevicius
    University Health Network, Toronto, ON, Canada
    Pharmacoepidemiol Drug Saf 16:207-15. 2007
    ..To assess the degree of concordance between the information (drug quantity, days' supply, and daily dose) recorded on hospital discharge prescriptions and what appears in a public drug insurance electronic claims database...
  4. ncbi request reprint Acute treatment of myocardial infarction in Canada 1999-2002
    Cynthia A Jackevicius
    Pharmacy Department, University Health Network Toronto General Hospital, Toronto, Ontario M5G 2C4
    Can J Cardiol 21:145-52. 2005
    ..Therapy for management of acute myocardial infarction (AMI) varies according to patient, prescriber and geographical characteristics...
  5. ncbi request reprint Routine use of glycoprotein IIb/IIIa inhibitor therapy is associated with an improved in-hospital outcome after percutaneous coronary intervention: Insights from a large, prospective, single-centre registry
    Cynthia A Jackevicius
    University Health Network, Toronto, Ontario
    Can J Cardiol 21:27-32. 2005
    ..Clinical trials have demonstrated the benefit of glycoprotein IIb/IIIa inhibitors (GPIs) with stenting in the setting of percutaneous coronary intervention (PCI) in reducing adverse cardiac outcomes...
  6. ncbi request reprint Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001
    Cynthia A Jackevicius
    Pharmacy Department, University Health Network Toronto General Hospital, Toronto, Ontario, Canada
    Can J Cardiol 19:1359-66. 2003
    ..There is increasing interest in studying trends in drug utilization because drug costs are the fastest growing sector of the health care system...
  7. ncbi request reprint Adherence with statin therapy in elderly patients with and without acute coronary syndromes
    Cynthia A Jackevicius
    Department of Health Policy, Management, and Evaluation, Pharmacy Department and Women s Health Program, University Health Network Toronto General Hospital, 200 Elizabeth St, Toronto, Ontario, Canada M5G 2C4
    JAMA 288:462-7. 2002
    ..Research prior to these trials of older lipid-lowering agents demonstrated low levels of 1-year adherence...
  8. pmc The use of lipid-lowering therapy for secondary prevention in patients undergoing percutaneous coronary intervention
    Jessica M Ma
    Pharmacy Department, Toronto East General Hospital, Canada
    Can J Cardiol 22:419-23. 2006
    ....
  9. ncbi request reprint Safety of glycoprotein IIb/IIIa inhibitors in urgent or emergency coronary artery bypass graft surgery
    Doret K F Cheng
    General Medicine, Mount Sinai Hospital, Toronto, Ontario
    Can J Cardiol 20:223-8. 2004
    ..Eptifibatide and tirofiban appear to have favourable safety profiles compared with abciximab in the setting of emergency or urgent CABG after failed PCI...
  10. doi request reprint Use of ezetimibe in the United States and Canada
    Cynthia A Jackevicius
    University Health Network, Schulich Heart Centre, Toronto
    N Engl J Med 358:1819-28. 2008
    ..We sought to describe the adoption of ezetimibe relative to that of other lipid-lowering agents and compare its use in the two countries...
  11. ncbi request reprint Association between ACE inhibitors and acute pancreatitis in the elderly
    Roger M S Cheng
    Princess Margaret Hospital, Toronto, Ontario, Canada
    Ann Pharmacother 37:994-8. 2003
    ..At present, no epidemiologic studies examining the potential association between ACE inhibitors and acute pancreatitis have been identified...
  12. ncbi request reprint The importance of in-hospital statin therapy for patients with acute coronary syndromes
    Fran L Paradiso-Hardy
    Department of Pharmacy, Sunnybrook and Women s College Health Sciences Centre, Faculty of Pharmacy, University of Toronto, Ontario, Canada
    Pharmacotherapy 23:506-13. 2003
    ..Various strategies have been developed to aid in the implementation of in-hospital lipid-lowering therapy. Pharmacists can play a valuable role in optimizing drug therapy for dyslipidemia and ensuring long-term adherence...
  13. ncbi request reprint Anti-Xa monitoring of enoxaparin for acute coronary syndromes in patients with renal disease
    Jessica M Ma
    Department of Pharmaceutical Services, Toronto East General Hospital, Toronto, Ontario, Canada
    Ann Pharmacother 38:1576-81. 2004
    ..To account for the potentially delayed drug elimination in these patients, we developed guidelines for adjusting enoxaparin dosing based on anti-Xa monitoring...
  14. doi request reprint Incidence, predictors, and prognostic implications of hospitalization for late bleeding after percutaneous coronary intervention for patients older than 65 years
    Dennis T Ko
    Institute for Clinical Evaluative Sciences, Division of Cardiology, Schulich Heart Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    Circ Cardiovasc Interv 3:140-7. 2010
    ..The incidence of late bleeding after PCI, its independent predictors, and its prognostic importance in clinical practice has not been fully addressed...
  15. doi request reprint Cardiovascular outcomes after a change in prescription policy for clopidogrel
    Cynthia A Jackevicius
    Western University of Health Sciences, College of Pharmacy, 309 E Second St, Pomona, CA 91766, USA
    N Engl J Med 359:1802-10. 2008
    ....
  16. ncbi request reprint Use of OTC and herbal products in patients with cardiovascular disease
    Chantal Pharand
    Faculty of Pharmacy, Université de Montréal and Hôpital du Sacré Coeur de Montréal, Montreal, Quebec, Canada
    Ann Pharmacother 37:899-904. 2003
    ..The use of nonprescription and herbal products by the public is rising, resulting in an increased potential for adverse reactions or drug interactions in cardiac patients...
  17. pmc Indicators of quality of care for patients with acute myocardial infarction
    Jack V Tu
    The Institute for Clinical Evaluative Sciences, Toronto, Ont
    CMAJ 179:909-15. 2008
    ..We undertook this initiative to develop an updated set of evidence-based indicators to measure and improve the quality of care for this patient population...